Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Compugen Ltd. (CGEN)

« Back to company index

CGEN Chatter Timeline

Stock Ticker for CGEN

Most Active Tweeters for CGEN

UserTweets
@AmericanBanking 6
@bulletin_en 5
@TranscriptDaily 3
@StockNewsNow 2
@WKRBNews 2

Recent Tweets for CGEN

TranscriptDaily @TranscriptDaily
Compugen $CGEN Stock Rating Upgraded by Zacks Investment Research https://t.co/YypzLNXeqw
May 23rd 2019, 7:05pm
AmericanBanking @AmericanBanking
Compugen Ltd. Forecasted to Earn Q2 2019 Earnings of -$0.13 Per Share $CGEN https://t.co/BT5Yn6jHiC #stocks
May 23rd 2019, 6:05am
AmericanBanking @AmericanBanking
Jefferies Financial Group Equities Analysts Cut Earnings Estimates for Compugen Ltd. $CGEN https://t.co/yeISNiRlQp #stocks
May 23rd 2019, 6:05am
WKRBNews @WKRBNews
Analysts Offer Predictions for Compugen Ltd.’s Q1 2020 Earnings $CGEN https://t.co/uJ0gNBYvfL #markets
May 23rd 2019, 1:05am
StockNewsNow @StockNewsNow
$CGEN Compugen to Present at the Jefferies 2019 Healthcare Conference https://t.co/lEf4edeakB
May 22nd 2019, 10:05am
AmericanBanking @AmericanBanking
Q1 2020 Earnings Estimate for Compugen Ltd. Issued By Oppenheimer $CGEN https://t.co/tIHeEKxgpc #stocks
May 22nd 2019, 8:05am
macondailynews @macondailynews
Q1 2020 Earnings Estimate for Compugen Ltd. Issued By Oppenheimer $CGEN https://t.co/R1eCG7RlYu
May 22nd 2019, 8:05am
RatingsNetwork @RatingsNetwork
Oppenheimer Sets Compugen Q1 2020 Earnings Estimates at ($0.11) EPS. https://t.co/4SwQDbmn46 $CGEN #CGEN
May 22nd 2019, 8:05am
WKRBNews @WKRBNews
Compugen $CGEN Posts Quarterly Earnings Results, Beats Estimates By $0.03 EPS https://t.co/tDZqsxt0aw #markets
May 22nd 2019, 8:05am
bulletin_en @bulletin_en
Contrasting of Abeona Therapeutics Inc. $CGEN https://t.co/ZUGpsV1pq0
May 21st 2019, 8:05pm
BioTuesdays @BioTuesdays
$CGEN Compugen doses first patient in advanced solid tumor trial https://t.co/jh6ehE73NC
May 21st 2019, 12:05pm
dakotafinancial @dakotafinancial
Compugen $CGEN Issues Quarterly Earnings Results, Beats Estimates By $0.03 EPS https://t.co/tmzJbpQxh4
May 21st 2019, 8:05am
TranscriptDaily @TranscriptDaily
Compugen $CGEN Announces Earnings Results https://t.co/WKbuiz9jHD
May 21st 2019, 7:05am
stocknewstimes @stocknewstimes
Compugen $CGEN Announces Quarterly Earnings Results, Beats Estimates By $0.03 EPS https://t.co/aCZsHQvR4s
May 21st 2019, 7:05am
SleekMoneycom @SleekMoneycom
Compugen $CGEN Announces Quarterly Earnings Results, Beats Estimates By $0.03 EPS https://t.co/eviYD6h9Mh #investing
May 21st 2019, 7:05am
AmericanBanking @AmericanBanking
Compugen $CGEN Posts Earnings Results, Beats Estimates By $0.03 EPS https://t.co/6o0Y1E8UeZ #stocks
May 21st 2019, 7:05am
OlympiaReport @OlympiaReport
Head to Head Survey: Voyager Therapeutics $VYGR versus Compugen $CGEN https://t.co/KhHKn4KaHZ
May 21st 2019, 1:05am
SiteFocusHQ @SiteFocusHQ
$CGEN Qualitative Analysis of recent earnings identified Compugen Ltd. (NASDAQ: SUMR ) business focus on (drug,immu… https://t.co/HV32jdB3MX
May 20th 2019, 1:05pm
SeekingAlpha @SeekingAlpha
$CGEN - Compugen Ltd. (CGEN) CEO Anat Cohen-Dayag on Q1 2019 Results - Earnings Call Transcript https://t.co/s6hV7OFuhn
May 20th 2019, 12:05pm
StockNewsNow @StockNewsNow
$CGEN Compugen Doses First Patient in COM701/Opdivo® (Nivolumab) Combination Arm of Phase 1 Study in Patients With… https://t.co/voilYGVvmK
May 20th 2019, 11:05am
bulletin_en @bulletin_en
Compugen $CGEN Gets BidaskScore Higher Rating; Cohen & Steers Select Preferred & Income Fund $PSF Has 1.09 Sentiment https://t.co/Mla6pzLk9I
May 20th 2019, 10:05am
StockNewsWires @StockNewsWires
$CGEN: Compugen begins patient dosing in early-stage Cancer study: https://t.co/u1EKs3Lsgq
May 20th 2019, 8:05am
MarketCurrents @MarketCurrents
$CGEN - Compugen begins patient dosing in early-stage Cancer study https://t.co/CzJCLu5HKn
May 20th 2019, 8:05am
HottestStockNow @HottestStockNow
The Real Numbers Behind $CGEN Revealed https://t.co/WqYxrxzHAG
May 20th 2019, 8:05am
StockTexts @StockTexts
$CGEN Compugen Ltd. SEC Filing: Form 6-K https://t.co/CDLbCsaFic
May 20th 2019, 7:05am
bthefirsttoknow @bthefirsttoknow
$CGEN Compugen Doses First Patient in COM701/Opdivo® (Nivolumab) Combination Arm of Phase 1 Study in Patients With… https://t.co/LktsM2GGFX
May 20th 2019, 7:05am
newswithvalue @newswithvalue
$AZZ $CGEN: Earnings Scheduled For May 20, 2019: https://t.co/4k93RDDF6x
May 20th 2019, 4:05am
ZolmaxNews @ZolmaxNews
Head to Head Survey: Compugen $CGEN vs. Sutro Biopharma $STRO https://t.co/yG0NCljYDE
May 20th 2019, 3:05am
MarketChmln @MarketChmln
$CGEN to report earnings on May 20 BMO, with an expected move of ±11.3% https://t.co/ccd9VnUUAi
May 19th 2019, 11:05pm
TranscriptDaily @TranscriptDaily
Compugen $CGEN to Release Quarterly Earnings on Monday https://t.co/E5NwNhEn6o
May 19th 2019, 1:05am
AmericanBanking @AmericanBanking
Compugen $CGEN and Sutro Biopharma $STRO Head-To-Head Comparison https://t.co/Z9G98kxW7n #stocks
May 15th 2019, 4:05pm
TickerReport @TickerReport
Sutro Biopharma $STRO and Compugen $CGEN Head-To-Head Comparison https://t.co/8oFvTcESCR
May 15th 2019, 4:05pm
ChartMill @ChartMill
$CGEN has a bad technical rating, but it does show a decent setup pattern. https://t.co/6TUI9Bqnsp https://t.co/m13r0xqBHu
May 15th 2019, 9:05am
bulletin_en @bulletin_en
Reviewing GlycoMimetics Inc. $CGEN's results https://t.co/xr5jGcERjN
May 15th 2019, 12:05am
ZolmaxNews @ZolmaxNews
Zacks: Analysts Expect Compugen Ltd. $CGEN to Post -$0.17 EPS https://t.co/yzfB1H7S0Y
May 14th 2019, 4:05pm
bulletin_en @bulletin_en
Reviewing Amicus Therapeutics Inc. $CGEN's results https://t.co/yWV0REgSAX
May 13th 2019, 11:05pm
bulletin_en @bulletin_en
Comparison of Axovant Sciences Ltd. $CGEN https://t.co/i9IkDnQFvz
May 13th 2019, 9:05pm
AmericanBanking @AmericanBanking
Compugen $CGEN Scheduled to Post Quarterly Earnings on Monday https://t.co/ER1e8FrRu1 #stocks
May 13th 2019, 2:05am
bbnsnews @bbnsnews
Brokerages Expect Compugen Ltd. $CGEN to Post -$0.17 EPS https://t.co/mnzKrxiLY4
May 7th 2019, 6:05pm
AmericanBanking @AmericanBanking
Zacks: Brokerages Expect Compugen Ltd. $CGEN Will Announce Earnings of -$0.17 Per Share https://t.co/dmmocTmGJY #stocks
May 7th 2019, 6:05pm
FinZTribune @FinZTribune
Radius Health Inc. $CGEN Comparison side by side https://t.co/9vemqPZLme
May 5th 2019, 5:05pm
FinZTribune @FinZTribune
Reviewing Ovid Therapeutics Inc. $CGEN's results https://t.co/1udXCtuqso
May 3rd 2019, 7:05pm
dispatchtribune @dispatchtribune
Compugen $CGEN Stock Rating Lowered by Zacks Investment Research https://t.co/oLT26v78UM
May 3rd 2019, 12:05pm
israeli_bulls @israeli_bulls
$CGEN the bear pattern is confirmed & a SHORT signal is issued @ https://t.co/pQs9rdomHl. Short Level: 1235.9400 Target: 1161.78
May 1st 2019, 11:05am
dakotafinancial @dakotafinancial
Compugen $CGEN Downgraded by Zacks Investment Research to “Hold” https://t.co/hIwvdpgzcE
May 1st 2019, 9:05am
OlympiaReport @OlympiaReport
Compugen $CGEN Lowered to “Hold” at Zacks Investment Research https://t.co/IjUPyrbfPp
April 30th 2019, 8:04pm
israeli_bulls @israeli_bulls
$CGEN may go down 6% if the bear pattern is confirmed. Chk confirmation [70%] @ https://t.co/pQs9rdomHl. Short level:1252.0000.
April 30th 2019, 11:04am
OlympiaReport @OlympiaReport
-$0.17 Earnings Per Share Expected for Compugen Ltd. $CGEN This Quarter https://t.co/csRMVDWrsa
April 22nd 2019, 9:04pm
TheMarketsDaily @TheMarketsDaily
Compugen Ltd. $CGEN Expected to Announce Earnings of -$0.17 Per Share https://t.co/wbQoQjbo6x
April 20th 2019, 12:04pm
stocknewstimes @stocknewstimes
Compugen Ltd. $CGEN Expected to Announce Earnings of -$0.17 Per Share https://t.co/jH7hC92Dfy
April 20th 2019, 12:04pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.